These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3060361)

  • 1. An objective evaluation of once-daily sustained-release verapamil (480 mg) in chronic stable angina.
    Rodrigues EA; DasGupta P; Hains AD; Raftery EB
    Eur J Clin Pharmacol; 1988; 34(5):531-2. PubMed ID: 3060361
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-daily verapamil--an objective evaluation in stable angina pectoris using treadmill exercise testing.
    Raftery EB
    Br J Clin Pract Suppl; 1985 Jun; 42():17-23. PubMed ID: 3929824
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained-release verapamil in stable angina.
    Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():20-3. PubMed ID: 3151265
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained-release and instant-release verapamil in treatment of angina pectoris.
    Jespersen CM; Klitgaard NA; Nielsen H; Hansen JF
    Eur J Clin Pharmacol; 1989; 36(6):625-7. PubMed ID: 2776821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sustained-release verapamil in chronic stable angina pectoris.
    Weiner DA; Klein MD; Cutler SS
    Am J Cardiol; 1987 Feb; 59(4):215-8. PubMed ID: 3544792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina.
    Gibbs JS; McAlpine HM; Wright C; McLenachan JM; Sparrow J; Sutton G; Dargie HJ; Fox KM
    Int J Cardiol; 1991 Jun; 31(3):281-6. PubMed ID: 1879977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for the choice of calcium antagonists in chronic stable angina. An objective double-blind placebo-controlled comparison of nifedipine and verapamil.
    Subramanian VB; Bowles MJ; Khurmi NS; Davies AB; Raftery EB
    Am J Cardiol; 1982 Nov; 50(5):1173-9. PubMed ID: 6753557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ergometric evaluation of the therapeutic effect of prolonged oral administration of delayed-action verapamil on 20 patients with stable effort angina].
    Martiny W; Bottone W; Matta F; Cerrone G; Minelli M; Angelino PF
    Minerva Cardioangiol; 1978 Dec; 26(12):811-8. PubMed ID: 368679
    [No Abstract]   [Full Text] [Related]  

  • 9. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
    Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
    Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
    [No Abstract]   [Full Text] [Related]  

  • 10. Verapamil administered twice daily in stable angina pectoris.
    Tan AT; Quek S
    Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variation in the pharmacokinetics of verapamil.
    Jespersen CM; Frederiksen M; Hansen JF; Klitgaard NA; Sørum C
    Eur J Clin Pharmacol; 1989; 37(6):613-5. PubMed ID: 2612558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nifedipine and verapamil in unstable angina. Evaluation by the Holter method].
    Piccolo E; Cazzin R; Sartori F; Artusi L; Pascotto P
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II61-4. PubMed ID: 6763268
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the efficacy of verapamil in slow-release preparations in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6927458
    [No Abstract]   [Full Text] [Related]  

  • 14. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.
    Cutler NR; Anders RJ; Jhee SS; Sramek JJ; Awan NA; Bultas J; Lahiri A; Woroszylska M
    Am J Cardiol; 1995 Jun; 75(16):1102-6. PubMed ID: 7762493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bepridil in stable angina of effort: a double-blind comparison with verapamil].
    Matteoli S; Trappolini M; Galli V; Federici AR; Borgia MC; Greco V
    Cardiologia; 1988 Apr; 33(4):413-8. PubMed ID: 3044589
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled trial of verapamil for Prinzmetal's variant angina.
    Johnson SM; Mauritson DR; Willerson JT; Hillis LD
    N Engl J Med; 1981 Apr; 304(15):862-6. PubMed ID: 6782480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials.
    Scheidt S; Frishman WH; Packer M; Mehta J; Parodi O; Subramanian VB
    Am J Cardiol; 1982 Nov; 50(5):1185-90. PubMed ID: 6814226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil therapy for stable exertional angina pectoris.
    Weiner DA; Klein MD
    Am J Cardiol; 1982 Nov; 50(5):1153-7. PubMed ID: 6814225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficacy of verapamil in a slow-release preparation in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M; Antuofermo F; Rizzon P
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6765260
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of sustained release verapamil versus atenolol for 24 h protection from exercise-induced angina pectoris.
    Hopkinson ND; Hui KP; Smith MP; Hollinrake K
    Eur Heart J; 1991 Dec; 12(12):1273-7. PubMed ID: 1778191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.